Navigation Links
Clinical Study Proves Pollogen's TriPollar(TM) Radio Frequency Technology is Effective in the Treatment of Stretch Marks
Date:8/18/2009

TEL AVIV, Israel, August 18 /PRNewswire/ -- Pollogen's TriPollar(TM) technology, the most advanced 3rd generation radio frequency solution for facial and body contouring, has been clinically proven to be effective in treating stretch marks or striae distensae. The peer reviewed paper entitled "Treatment of striae distensae with a TriPollar radiofrequency device: a pilot study" authored by Dr Manuskiatti et al, has been published in the Journal of Dermatological Treatment. The abstract is available online at:

http://www.informaworld.com/10.1080/09546630903085278

In the clinical study, seventeen females with stretch marks underwent six weekly treatments with the apollo(TM) device-Pollogen's latest aesthetic solution based on TriPollar(TM) technology. Results showed that at one week after the final (sixth) treatment, 38.2% and 11.8% of the patients were assessed to have 25-50% and 51-75% improvement in the appearance of their stretch marks, respectively. The long term effect of the treatment was confirmed during the 6 weeks follow up which showed that a higher percentage of the patients were rated to have improvement of their stretch marks, including 26.5% and 5.9% showing 51-75% and >75% improvement, respectively. None of the participants were rated as having no improvement in their clinical appearance of stretch marks. Patient satisfaction was also measured and 65% of patients reported that they were very satisfied with the treatment, 23% were satisfied and 12% were slightly satisfied.

Dr. Manuskiatti commented: "Stretch marks are a skin condition that has been traditionally very challenging to treat. The study confirms that collagen remodeling induced by RF heating is an effective mechanism for improving the surface appearance of stretch marks. I am delighted that TriPollar(TM) technology delivered significant measurable results that were maintained during the long term follow-up examination and that patients reported a pain-free and pleasant experience".

Company Founder and CEO, Dr Zion Azar, stated: "Pollogen is dedicated to providing patients with a wide range of aesthetic solutions. In addition to facial rejuvenation and body sculpting, TriPollar(TM) is a fast, effective, non-invasive way to significantly reduce stretch marks. A primary audience for this treatment is post-pregnancy women who would like to eliminate abdominal stretch marks. Pollogen is delighted with the results of the clinical trial which provides clear scientific evidence supporting the safety and effectiveness of TriPollar(TM) technology."

About Pollogen:

Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar(TM) 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar(TM) technology powers a full line of clinically-proven, non-invasive and non-surgical treatment platforms for wrinkles, cellulite, circumference reduction and skin tightening. The flagship aesthetic devices, apollo(TM) and regen(TM) offer customers clinically-proven, safe and effective anti-aging beauty treatments that deliver immediate and long-lasting results. To learn more, please visit the Pollogen website at http://www.pollogen.com

    Contact:
    Abigail Marks
    Tel: +972-54-244-5807
    abigail_m@pollogen.com



'/>"/>
SOURCE Pollogen
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
2. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
3. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
4. Radius Investigational Bone Anabolic Agent, BA058, Increased Bone Mineral Density (BMD) at Key Fracture Sites in Phase 2 Clinical Trial in Postmenopausal Osteoporosis
5. Project Zero Delay Accelerates Drugs Path to Clinical Trial
6. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
7. Unlikely Treatment Identified by BrainCells Neurogenesis Platform Improved Clinical Outcomes in Patients Suffering From Depression
8. Terumo Cardiovascular Systems Initiates U.S. Clinical Trial for Anaconda(TM) AAA Stent Graft System
9. R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
10. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
11. R-Tech Ueno, Ltd. Completes Phase 1 Clinical Study on RK-023
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... 5, 2016  As people age, it is natural ... recommended screenings and tests that are linked with certain ... for the majority of aging individuals, hearing health is ... the 37.5 million American adults who report some trouble ... make hearing health a 2016 healthy aging priority.[1] ...
(Date:2/5/2016)... Aethlon Medical, Inc. (Nasdaq: AEMD ), today announced that ... at Source Capital Group,s 2016 Disruptive Growth & Healthcare Conference ... p.m. ET on Wednesday, February 10, 2016.  Mr. Joyce will ... 3:15 p.m. ET. http://www.aethlonmedical.com .  The webcast will ... of the live event. The panel discussion will not be ...
(Date:2/5/2016)... , Feb. 5, 2016  Zimmer Biomet Holdings, Inc. ... the previously announced underwritten secondary offering of 11,027,558 shares ... consisting of affiliates of Blackstone and Goldman Sachs.  The ... initial price of $96.45 per share. The selling stockholders ...  Neither Zimmer Biomet nor any of its directors, officers ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Steven Tonkinson, 36, of Coconut Grove, Florida, ... since it started in 2003. This year, he ran all 26.2 miles with a ... NBA team the Miami Heat. , This Sunday, while many are watching the Superbowl, ...
(Date:2/5/2016)... ... February 05, 2016 , ... Successful ... for new clinical and scientific initiatives have all marked the last 12 months ... President and CEO of the nation’s oldest cancer center, Candace S. Johnson, PhD, ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... Looking for ... may be at the tips of your toes. Foot massage, whether administered by a ... pure comfort and relaxation. The American Board of Multiple Specialties in Podiatry ...
(Date:2/5/2016)... ... 05, 2016 , ... US Sports Camps , official operators of Nike ... high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque New ... ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to be ...
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... to search for and donate to Give To Cure’s campaign that is crowdfunding clinical ... lets users make and share payments through a smart device. In 2015 alone, Venmo ...
Breaking Medicine News(10 mins):